Sandoz Senna
Natural health product licensed in Canada
- Licence holder
- Sandoz Canada Inc.
- NPN or DIN-HM
- 02247389
- Status
- Active licence
- Licence date
- 26 November 2007
- Revision date
- 15 August 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
D&C Yellow No. 10 Lake, cellulose, Laque d'aluminium bleu FD&C n° 1, Cellulose, Microcrystalline and Carboxymethylcellulose Sodium, Caramel, Béhénate de glycéryle, Acide stéarique, Silicon dioxide colloïdal, FD&C Yellow #6 Aluminium Lake, Phosphate de calcium, dibasique, anhydre, Laque d'aluminiium FD&C rouge n° 40
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 5 years | minimum: 2 Comprimé ; maximum: 4 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | minimum: 2 Comprimé ; maximum: 4 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Adultes | minimum: 12 years | minimum: 2 Comprimé ; maximum: 4 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Stimulant laxative Catharic Relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use in presence of abdominal pain, nausea, fever or vomiting. Do not use within 2 hours after taking any other medication because the desire effect of the other medicine may be reduced. Do not use for more than one week unless your health care provider has ordered a special schedule for you. Overuse or extend use may cause dependence for bowel function.
Source
Official Health Canada record, licence 02247389
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging